Джейсон Фанг - Код диабета. Научные данные о том, как диабет 2-го типа стал самой «внезапной» болезнью столетия, и простая программа восстановления без инъекций и лекарств

32. Сюн П. и другие. Оригинальная публикация: Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2013; 98(6): 1543–1554.

33. Крситлиб Р. и другие. Оригинальная публикация: Is insulin the link between hypertension and obesity? Hypertension. 1985; 7(Suppl II): II-54–II-57; Excess exposure to insulin is the primary cause of insulin resistance and its associated atherosclerosis. Curr Mol Pharmacol. 2011; 4(3): 154–166.

34. Рейкер Р. и другие. Оригинальная публикация: Positive inotropic action of insulin on piglet heart. Yale. J. Biol. Med., 1975; 48: 353–360.

35. Бьоннер Г. Оригинальная публикация: Hyperinsulinemia, insulin resistance, and hypertension. J Cardiovasc Pharmacol. 1994; 24(Suppl 2): S39–49.

36. Саттар Н. и другие. Оригинальная публикация: Serial metabolic measurements and conversion to type 2 diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2007; 56(4): 984–991.

37. Колата Г. Оригинальная публикация: Skinny and 119 pounds, but with the health hallmarks of obesity. New York Times. 2016 July 22. Адрес ссылки: https://www.nytimes. com/2016/07/26/ health/skinny-fat.html?mcubz=3

1. Геллер А. и другие. Оригинальная публикация: National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med. 2014 May; 174(5): 678–686.

2. Оригинальная публикация: The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14): 977–986.

3. Оригинальная публикация: The DCCT/EDIC Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353(25): 2643–2653.

4. На основе данных, полученных от The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care. 2001 Oct; 24(10): 1711–1721.

5. Пернелл Дж. и другие. Оригинальная публикация: The effect of excess weight gain with intensive diabetes treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation. 2013 January 15; 127(2): 180–187. doi: 10.1161/CIRCULATIONAHA.111.077487. Доступ 2017 июнь 6.

6. Миус М. Оригинальная публикация: High cumulative insulin exposure: a risk factor of atherosclerosis in type 1 diabetes? Atherosclerosis. 2005 Jul; 181(1): 185–192.

7. Оригинальная публикация: UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep 12; 352(9131): 837-53.

8. Оригинальная публикация: UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998 Sep 12; 352(9131): 854-865.

9. Розен С. и другие. Оригинальная публикация: The rosiglitazone story—lessons from an FDA Advisory Committee Meeting. N Engl J Med. 2007; 357(9): 844–846.

10. Оригинальная публикация: The ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12; 358(24): 2545–2559.

11. Оригинальная публикация: The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358(24): 2560–2572.

12. Дакворт У. и другие. Оригинальная публикация: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360(2): 129–139.

13. Оригинальная публикация: The ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med. 2012; 367(4): 319–328.

14. Оригинальная публикация: The ACCORD Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcome. N Engl J Med. 2011; 364(9): 818–828; Hayward R. A. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2015; 372(23): 2197–2206; Zoungas S. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014; 371(15): 1392–1406.

15. Кинг П. и другие. Оригинальная публикация: The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999; 48(5): 643–648.

16. Соедама-Мутху С. и другие. Оригинальная публикация: Relationship between risk factors and mortality in type 1 diabetic patients in Europe. The EURODIAB Prospective Complications Study (PCS). Diabetes Care. 2008; 31(7): 1360–1366.

17. Байн С. и другие. Оригинальная публикация: Characteristics of type 1 diabetes of over 50 years duration (the Golden Years Cohort). Diabetic Medicine. 2003; 20(10): 808–811.

18. Крофтс К. и другие. Оригинальная публикация: Hyperinsulinemia: a unifying theory of chronic disease? Diabesity. 2015; 1(4): 34–43; 41. Meinert C. L. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes. 1970; 19(Suppl): 789–830.

19. Юдкин Дж. и другие. Оригинальная публикация: Intensified glucose lowering in type 2 diabetes: time for a reappraisal. Diabetologia. 2010 Oct; 53(10): 2079–2085.

20. Прадан Д. и другие. Оригинальная публикация: Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes The LANCET Randomized Trial. JAMA. 2009; 302(11): 1186–1194; Ridker P. M. и другие C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342(12): 836–843.

21. Хаффнер С. и другие Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med, 1998; 339(4): 229–234.

22. Мадонна Р., Де Катерина Р. Оригинальная публикация: Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signalling. Thromb Haemost. 2009; 101(2): 345–350; Okouchi M. и другие High insulin enhances neutrophil transendothelial migration through increasing surface expression of platelet endothelial cell adhesion molecule-1 via activation of mitogen activated protein kinase. Diabetologia. 2002; 45(10): 1449–1456; Pfeifle B., Ditschuneit H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia. 1981; 20(2): 155–158; Stout R. W. и другие Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res. 1975; 36: 319–327; Iida K. T. и другие Insulin up-regulates tumor necrosis factor-alpha production in macrophages through an extracellular-regulated kinase-dependent pathway. J Biol Chem. 2001; 276(35): 32531–32537.

23. Ренсинг К. Оригинальная публикация: Endothelial insulin receptor expression in human atherosclerotic plaques: linking micro– and macrovascular disease in diabetes? Atherosclerosis. 2012; 222(1): 208–215.

24. Дафф Г., Мак Миллан Г. Оригинальная публикация: The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. J. Exp. Med. 1949; 89(6): 611–630.

25. Селвин Е. Оригинальная публикация: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010; 362(9): 800–811.

26. Кьюрри К., Пул К. и другие. Оригинальная публикация: Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. 2013; 98(2): 668–677.

27. Руми К. и другие. Оригинальная публикация: Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes. JAMA. 2014 Jun 11; 311(22): 2288–2296.

28. Кьюрри К., Питерс Дж. и другие. Оригинальная публикация: Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010; 375(9713): 481–489.

29. На основе данных, полученных от Гэмбл Дж. и других Insulin use and increased risk of mortality in type 2 diabetes. Diabetes, Obes Metab. 2010 Jan; 12(1): 47–53.

30. Деспре Дж. и другие. Оригинальная публикация: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl. J. Med. 1996; 334(15): 952–957.

31. Гэмбл Дж. и другие. Оригинальная публикация: Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab. 2010; 12(1): 47–53.

32. Марголис Д. и другие. Оригинальная публикация: Association between serious ischemic cardiac outcomes and medications used to treat diabetes. Pharmacoepidemiol Drug Saf. 2008 Aug; 17(8): 753–759.

33. Колайко Д. и другие. Оригинальная публикация: A1C and cardiovascular outcomes in type 2 diabetes. Diabetes Care. 2011; 34(1): 77–83; In T2DM, lower HbA1c associated with elevated mortality risk vs moderate HbA1c | ADA. Univadis. 2016 Jun 13. Адрес ссылки: http://www. univadis.com/viewarticle/in-t2dm-lower-hba1c-associated-with-elevatedmortality-risk-vs-moderate-hba1c-ada-414150. Доступ 2017 июнь 6.

34. Стокенброек Р. и другие. Оригинальная публикация: High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events. Atherosclerosis. 2015 Jun; 240(2): 318–323.

35. Смук С. и другие. Оригинальная публикация: Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J. 2005 Jan; 149(1): 168–174.

36. Джонсон Дж., Карстенсен Б. и другие. Оригинальная публикация: Diabetes and cancer: evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia. 2012; 55(6): 1607–1618.